ARTICLE | Finance
Biotech down again in 3Q19
Winners, losers by market cap tier in 3Q19
October 4, 2019 7:43 PM UTC
Biotech stocks are continuing a downward trend, with all market cap tiers losing value in 3Q19, leading to a total quarterly loss of $88.8 billion.
Companies valued at $1-$4.9 billion, $5-$9.9 billion and above $10 billion saw median losses of 9%...